首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis
【2h】

Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis

机译:趋化因子25诱导的信号传导抑制结肠癌的侵袭和转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemotactic cytokines (chemokines) can help regulate tumor cell invasion and metastasis. Here, we show that chemokine 25 (CCL25) and its cognate receptor chemokine receptor 9 (CCR9) inhibit colorectal cancer (CRC) invasion and metastasis. We found that CCR9 protein expression levels were highest in colon adenomas and progressively decreased in invasive and metastatic CRCs. CCR9 was expressed in both primary tumor cell cultures and colon-cancer-initiating cell (CCIC) lines derived from early-stage CRCs but not from metastatic CRC. CCL25 stimulated cell proliferation by activating AKT signaling. In vivo, systemically injected CCR9+ early-stage CCICs led to the formation of orthotopic gastrointestinal xenograft tumors. Blocking CCR9 signaling inhibited CRC tumor formation in the native gastrointestinal CCL25+ microenvironment, while increasing extraintestinal tumor incidence. NOTCH signaling, which promotes CRC metastasis, increased extraintestinal tumor frequency by stimulating CCR9 proteasomal degradation. Overall, these data indicate that CCL25 and CCR9 regulate CRC progression and invasion and further demonstrate an appropriate in vivo experimental system to study CRC progression in the native colon microenvironment.
机译:趋化性细胞因子(趋化因子)可以帮助调节肿瘤细胞的侵袭和转移。在这里,我们显示趋化因子25(CCL25)及其同源受体趋化因子受体9(CCR9)抑制结直肠癌(CRC)的侵袭和转移。我们发现CCR9蛋白表达水平在结肠腺瘤中最高,而在浸润性和转移性CRC中逐渐降低。 CCR9在源自早期CRC而非转移性CRC的原发肿瘤细胞培养物和结肠癌起始细胞(CCIC)系中表达。 CCL25通过激活AKT信号传导刺激细胞增殖。在体内,全身注射CCR9 + 早期CCICs导致原位胃肠异种移植肿瘤的形成。在自然胃肠道CCL25 + 微环境中,阻断CCR9信号传导抑制了CRC肿瘤的形成,同时增加了肠道外肿瘤的发生率。促进CRC转移的NOTCH信号通过刺激CCR9蛋白酶体降解而增加了肠外肿瘤的发生频率。总体而言,这些数据表明CCL25和CCR9调节CRC的进展和侵袭,并进一步证明了一种合适的体内实验系统可用于研究天然结肠微环境中CRC的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号